vs
Primis Financial Corp.（FRST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Primis Financial Corp.的1.7倍（$75.5M vs $45.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.0%）
Primis金融集团是一家总部位于美国的金融控股公司，运营多家全服务银行子公司，面向个人及企业客户提供存款、贷款、按揭、财富管理等多元化金融服务，核心业务覆盖美国中大西洋沿岸区域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FRST vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$45.6M
两年增速更快
PBYI
近两年复合增速
13.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.6M | $75.5M |
| 净利润 | $7.3M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 16.0% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 200.0% | — |
| 每股收益（稀释后） | $0.30 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRSTPBYI
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $75.5M | ||
| Q3 25 | $41.0M | $54.5M | ||
| Q2 25 | $43.2M | $52.4M | ||
| Q1 25 | $58.7M | $46.0M | ||
| Q4 24 | $38.8M | $59.1M | ||
| Q3 24 | $37.3M | $80.5M | ||
| Q2 24 | $35.7M | $47.1M |
净利润FRSTPBYI
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | — | ||
| Q3 25 | $6.8M | $8.8M | ||
| Q2 25 | $2.4M | $5.9M | ||
| Q1 25 | $22.6M | $3.0M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $1.2M | $20.3M | ||
| Q2 24 | $3.4M | $-4.5M |
毛利率FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | 22.7% | ||
| Q3 25 | 21.3% | 17.6% | ||
| Q2 25 | 6.9% | 12.7% | ||
| Q1 25 | 41.9% | 8.7% | ||
| Q4 24 | -123.0% | 22.6% | ||
| Q3 24 | -3.1% | 27.4% | ||
| Q2 24 | 7.8% | -4.6% |
净利率FRSTPBYI
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 16.7% | 16.2% | ||
| Q2 25 | 5.6% | 11.2% | ||
| Q1 25 | 38.6% | 6.5% | ||
| Q4 24 | -100.3% | — | ||
| Q3 24 | 3.3% | 25.2% | ||
| Q2 24 | 9.6% | -9.6% |
每股收益（稀释后）FRSTPBYI
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $0.26 | ||
| Q3 25 | $0.28 | $0.17 | ||
| Q2 25 | $0.10 | $0.12 | ||
| Q1 25 | $0.92 | $0.06 | ||
| Q4 24 | $-0.95 | $0.40 | ||
| Q3 24 | $0.05 | $0.41 | ||
| Q2 24 | $0.14 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $427.2M | $130.3M |
| 总资产 | $4.3B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FRSTPBYI
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $97.5M | ||
| Q3 25 | $63.9M | $94.4M | ||
| Q2 25 | $94.1M | $96.0M | ||
| Q1 25 | $57.0M | $93.2M | ||
| Q4 24 | $64.5M | $101.0M | ||
| Q3 24 | $77.3M | $96.7M | ||
| Q2 24 | $66.6M | $96.8M |
总债务FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益FRSTPBYI
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $130.3M | ||
| Q3 25 | $382.2M | $115.3M | ||
| Q2 25 | $376.4M | $104.7M | ||
| Q1 25 | $375.6M | $97.1M | ||
| Q4 24 | $351.8M | $92.1M | ||
| Q3 24 | $381.0M | $71.1M | ||
| Q2 24 | $376.0M | $48.5M |
总资产FRSTPBYI
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $216.3M | ||
| Q3 25 | $4.0B | $202.9M | ||
| Q2 25 | $3.9B | $194.9M | ||
| Q1 25 | $3.7B | $196.2M | ||
| Q4 24 | $3.7B | $213.3M | ||
| Q3 24 | $4.0B | $220.7M | ||
| Q2 24 | $4.0B | $205.0M |
负债/权益比FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $14.4M | ||
| Q3 25 | $-11.4M | $9.7M | ||
| Q2 25 | $-41.0M | $14.1M | ||
| Q1 25 | $34.4M | $3.6M | ||
| Q4 24 | $19.5M | $15.6M | ||
| Q3 24 | $6.1M | $11.0M | ||
| Q2 24 | $52.3M | $1.0M |
自由现金流FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $18.3M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 47.3% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% |
现金转化率FRSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | — | ||
| Q3 25 | -1.67× | 1.10× | ||
| Q2 25 | -16.82× | 2.41× | ||
| Q1 25 | 1.52× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.93× | 0.54× | ||
| Q2 24 | 15.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
PBYI
暂无分部数据
